AAAAAA

   
Results: 1-11 |
Results: 11
Growth hormone and insulin-like growth factor-1: effects on the growth of glioma cell lines
Authors: Friend, KE Khandwala, HM Flyvbjerg, A Hill, H Li, J McCutcheon, IE
Citation: Ke. Friend et al., Growth hormone and insulin-like growth factor-1: effects on the growth of glioma cell lines, GROWTH H I, 11(2), 2001, pp. 84-91
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
Authors: van der Lely, AJ Hutson, RK Trainer, PJ Besser, GM Barkan, AL Katznelson, L Klibanski, A Herman-Bonert, V Melmed, S Vance, ML Freda, PU Stewart, PM Friend, KE Clemmons, DR Johannsson, G Stavrou, S Cook, DM Phillips, LS Strasburger, CJ Hacker, S Zib, KA Davis, RJ Scarlett, JA Thorner, M
Citation: Aj. Van Der Lely et al., Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist, LANCET, 358(9295), 2001, pp. 1754-1759
Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice
Authors: McCutcheon, IE Flyvbjerg, A Hill, H Li, J Bennett, WF Scarlett, JA Friend, KE
Citation: Ie. Mccutcheon et al., Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice, J NEUROSURG, 94(3), 2001, pp. 487-492
Targeting the growth hormone axis as a therapeutic strategy in oncology
Authors: Friend, KE
Citation: Ke. Friend, Targeting the growth hormone axis as a therapeutic strategy in oncology, GROWTH H I, 10, 2000, pp. S45-S46
The effects of insulin-like growth factors on tumorigenesis and neoplasticgrowth
Authors: Khandwala, HM McCutcheon, IE Flyvbjerg, A Friend, KE
Citation: Hm. Khandwala et al., The effects of insulin-like growth factors on tumorigenesis and neoplasticgrowth, ENDOCR REV, 21(3), 2000, pp. 215-244
Pituitary carcinoma containing gonadotropins: Treatment by radical excision and cytotoxic chemotherapy: Case report
Authors: McCutcheon, IE Pieper, DR Fuller, GN Benjamin, RS Friend, KE Gagel, RF
Citation: Ie. Mccutcheon et al., Pituitary carcinoma containing gonadotropins: Treatment by radical excision and cytotoxic chemotherapy: Case report, NEUROSURGER, 46(5), 2000, pp. 1233-1239
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
Authors: Trainer, PJ Drake, WM Katznelson, L Freda, PU Herman-Bonert, V van der Lely, AJ Dimaraki, EV Stewart, PM Friend, KE Vance, ML Besser, GM Scarlett, JA Thorner, MO Parkinson, C Klibanski, A Powell, JS Barkan, AL Sheppard, MC Maldonado, M Rose, DR Clemmons, DR Johannson, G Bengtsson, BA Stavrou, S Kleinberg, DL Cook, DM Phillips, LS Bidlingmaier, M Strasburger, CJ Hackett, S Zib, K Bennett, WF Davis, RJ
Citation: Pj. Trainer et al., Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant, N ENG J MED, 342(16), 2000, pp. 1171-1177
Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth
Authors: McCutcheon, IE Friend, KE Gerdes, TM Zhang, BM Wildrick, DM Fuller, GN
Citation: Ie. Mccutcheon et al., Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth, J NEUROSURG, 92(2), 2000, pp. 306-314
Cabergoline in prolactinomas
Authors: Fierz, AB Kaufman, DI Lee, AG Eggenberger, ER Friend, KE
Citation: Ab. Fierz et al., Cabergoline in prolactinomas, NEURO-OPHTH, 22(1), 1999, pp. 37-46
Growth hormone receptor expression and function in meningiomas: effect of a specific receptor antagonist
Authors: Friend, KE Radinsky, R McCutcheon, IE
Citation: Ke. Friend et al., Growth hormone receptor expression and function in meningiomas: effect of a specific receptor antagonist, J NEUROSURG, 91(1), 1999, pp. 93-99
Surgical strategy for the treatment of medullary thyroid carcinoma
Authors: Fleming, JB Lee, JE Bouvet, M Schultz, PN Sherman, SI Sellin, RV Friend, KE Burgess, MA Cote, GJ Gagel, RF Evans, DB
Citation: Jb. Fleming et al., Surgical strategy for the treatment of medullary thyroid carcinoma, ANN SURG, 230(5), 1999, pp. 697-707
Risultati: 1-11 |